Management review—CMS’s implementation of the Quality Payment Program: The OIG will describe the timelines and key milestones the CMS has established for implementing the Quality Payment Program provisions of MACRA and will identify the key challenges and potential vulnerabilities the CMS is facing during implementation.
Medicare Part D rebates related to drugs dispensed by 340B pharmacies: The OIG will determine the upper bound of what could be saved if pharmaceutical manufacturers paid rebates for drugs dispensed through the Medicare Part D program at 340B covered entities and contract pharmacies.
In Closing
The OIG Work Plan offers advisory opinions, provider-specific compliance guidelines, fraud alerts and special bulletins, and it is a valuable resource for providers, practice administrators and compliance officers to use when identifying internal audit and review topics for the upcoming year. Providers and their staff should become familiar with the Work Plan and use it to help identify potential risk areas. To view the complete 2017 OIG Work Plan, visit the OIG website.
For additional information on updating or creating a compliance plan for your organization, contact the ACR certified compliance staff via email at [email protected].